bibliographicCitation |
Asukai Y, Valladares A, Camps C, Wood E, Taipale K, Arellano J, Cassinello A, Sacristán JA, Dilla T. Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population. BMC Cancer. 2010 Jan 29;10():26. PMID: 20113499; PMCID: PMC2841662. |